The negligible effects of the antifungal natamycin on cholesterol-dipalmitoyl phosphatidylcholine monolayers may explain its low oral and topical toxicity for mammals.

Arima, Anderson A; Pavinatto, Felippe J; Oliveira, Osvaldo N; Gonzales, Eduardo R P

Arima, Anderson A; Pavinatto, Felippe J; Oliveira, Osvaldo N; Gonzales, Eduardo R P.

Afiliación

Arima AA; Faculty of Sciences and Technology, State University of São Paulo, Unesp, Presidente Prudente, SP, Brazil.
Pavinatto FJ; São Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil.
Oliveira ON; São Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil.
Gonzales ERP; Faculty of Sciences and Technology, State University of São Paulo, Unesp, Presidente Prudente, SP, Brazil. Electronic address: eperez@fct.unesp.br.

Colloids Surf B Biointerfaces ; 122: 202-208, 2014 Oct 01.

Article en En | MEDLINE | ID: mdl-25048356

Asunto(s)

1,2-Dipalmitoilfosfatidilcolina/química; Antifúngicos/farmacología; Colesterol/química; Natamicina/farmacología; Administración Oral; Animales; Antifúngicos/administración & dosificación; Antifúngicos/toxicidad; Mamíferos; Natamicina/administración & dosificación; Natamicina/toxicidad

Palabras clave

Cholesterol; Dipalmitoyl phosphatidylcholine (DPPC); Langmuir films; Natamycin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: 1,2-Dipalmitoilfosfatidilcolina / Natamicina / Colesterol / Antifúngicos Límite: Animals Idioma: En Revista: Colloids Surf B Biointerfaces Asunto de la revista: QUIMICA Año: 2014 Tipo del documento: Article País de afiliación: Brasil

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google